People paying privately for weight-loss drug Mounjaro in the UK face a rise in the cost of the treatment after manufacturer ...

As the Dec. 31 end to federal subsidies for federal health care nears, pressure is mounting on insurers, providers, and the ...

Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.

Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out ...